225
Participants
Start Date
July 29, 2022
Primary Completion Date
December 29, 2023
Study Completion Date
December 29, 2023
OTT166
Participants will receive OTT166 ophthalmic solution
Vehicle control
Participants will receive vehicle control
Clinical Site 109, Liverpool
Clinical Site 162, Rochester
Clinical Site 115, Kingston
Clinical Site 163, Baltimore
Clinical Site 145, Baltimore
Clinical Site 103, Hagerstown
Clinical Site 159, Lynchburg
Clinical Site 165, Raleigh
Clinical Site 130, Beaufort
Clinical Site 131, Jacksonville
Clinical Site 157, Coral Springs
Clinical Site 110, Miami
Clinical Site 106, Fort Lauderdale
Clinical Site 117, Winter Haven
Clinical Site 119, Nashville
Clinical Site 169, Memphis
Clinical Site 168, Germantown
Clinical Site 155, Southaven
Clinical Site 166, Louisville
Clinical Site 152, Dublin
Clinical Site 143, Beachwood
Clinical Site 120, Cleveland
Clinical Site 141, Detroit
Clinical Site 133, Rapid City
Clinical Site 146, Oak Forest
Clinical Site 128, Springfield
Clinical Site 139, Lenexa
Clinical Site 167, Metairie
Clinical Site 122, Edmond
Clinical Site 147, Burleson
Clinical Site 132, Fort Worth
Clinical Site 156, Houston
Clinical Site 102, Bellaire
Clinical Site 108, Bellaire
Clinical Site 137, San Antonio
Clinical Site 144, Texas City
Clinical Site 126, McAllen
Clinical Site 161, Austin
Clinical Site 150, Phoenix
Clinical Site 123, Peoria
Clinical Site 118, Albuquerque
Clinical Site 101, Reno
Clinical Site 111, Beverly Hills
CinCor Site 171, Torrance
Clinical Site 121, Pasadena
Clinical Site 127, Pasadena
Clinical Site 113, Encino
Clinical Site 116, Riverside
Clinical Site 129, Huntington Beach
Clinical Site 138, Fresno
Clinical Site 142, Rancho Cordova
Clinical Site 125, Sacramento
Clinical Site 112, ‘Aiea
Clinical Site 135, Portland
Clinical Site 158, Springfield
Clinical Site 149, Seattle
Clinical Site 148, Spokane
Clinical Site 160, Walnut Creek
Clinical Site 153, St. Petersburg
Clinical Site 154, Indianapolis
Clinical Site 151, Boston
Clinical Site 104, Boston
Clinical Site 105, Bloomfield
Clinical Site 136, Cherry Hill
Clinical Site 114, Teaneck
Clinical Site 164, Knoxville
Clinical Site 140, San Antonio
Clinical Site 201, Arecibo
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
OcuTerra Therapeutics, Inc.
INDUSTRY